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Introduction
The separation of daughter cells at the end of cell division en-
sures accurate segregation of genomic and cytoplasmic materi-
als. In animal cells, this process, known as cytokinesis, requires 
the formation and ingression of a cleavage furrow (CF) that 
bisects the mother cell after chromosomes reach the spindle 
poles. In many organisms, the force that drives furrow ingres-
sion is the assembly and contraction of actomyosin filaments 
that often form a contractile ring (CR). The CR is a very dy-
namic structure in which actomyosin filaments are continuously 
assembled and disassembled. Compelling evidence indicates 
that the small GTPase RhoA controls CR assembly and dynam-
ics during cytokinesis (Piekny et al., 2005). This GTPase cycles 
between an inactive GDP-bound form and an active GTP-bound 
form, and this RhoA flux seems important for CR dynam-
ics (Miller and Bement, 2008). RhoA can promote profilin- 
mediated actin polymerization by activating members of the 
family of formin-related proteins and, in parallel, can control 
myosin activity through the phosphorylation of the myosin 
regulatory light chain (MRLC) by Rho kinase (ROK). Another 
putative RhoA effector, Citron kinase (CIT-K), has also been 
implicated in cytokinesis in both flies and humans (Madaule 
et al., 1998; D’Avino et al., 2004; Echard et al., 2004; Naim 
et al., 2004; Shandala et al., 2004). Initial studies in human cells 
indicated that CIT-K could also regulate myosin contractility 
by phosphorylating MRLC (Madaule et al., 2000; Yamashiro 
et al., 2003). However, this model has been challenged by the 
finding that the Drosophila melanogaster CIT-K orthologue 
Sticky (Sti) is not required for furrow ingression and MRLC 
phosphorylation but rather for the final separation of the 
daughter cells and proper organization of the CR structure in 
late cytokinesis (D’Avino et al., 2004; Echard et al., 2004; Naim 
et al., 2004; Shandala et al., 2004; Dean and Spudich, 2006).
Here, we describe that Sti localizes to the CF via associa-
tion of a predicted coiled-coil (CC) region with actin and myo-
sin and does not require direct physical interaction with RhoA 
as previously suggested for CIT-K (Eda et al., 2001). Further-
more, we show that Sti depletion perturbs RhoA localization 
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RNAi cells did not show any localization of Sti to the equatorial 
cortex, but in 38.5% of cells, we could detect Sti inside the cyto-
plasm close to microtubules (Fig. 2 A), in agreement with find-
ings in human cells (Eda et al., 2001). These Sti structures 
associated with microtubules are unlikely to represent remnants 
of partially ingressed furrows because they do not contain other 
CR components (Fig. S1 B). We then investigated whether CR 
assembly, which is regulated by RhoA, was also required for Sti 
localization. In the large majority (80.8%, n = 120) of cells de-
pleted of the nonmuscle myosin II encoded by the gene zipper, 
Sti was found to localize either inside the cytoplasm or to only 
one side of the equatorial cortex, always in proximity of micro-
tubules (Fig. 2 B). The remaining 19.2% of zipper RNAi cells 
did not show any specific localization of Sti (Fig. 2 B). In con-
trast, Rho1 was consistently found at the cell’s equatorial cortex 
after Zipper depletion, even when Sti was absent (Fig. 2 C). 
Similarly, F-actin depolymerization prevented accumulation of 
Sti, but not Rho1, at the equatorial cortex (Fig. 2 D). Collec-
tively, these results indicate that CR assembly is essential for 
Sti localization and raise the possibility that physical interaction 
with Rho1 might not be directly responsible for Sti recruitment 
to the CF as previously proposed for CIT-K (Eda et al., 2001).
Sti localizes to the CF via a CC region that 
associates with actin and myosin
To identify the region responsible for Sti localization to the 
CF, we generated cell lines stably expressing several Sti frag-
ments tagged with GFP (Fig. 3 A). Sti contains an N-terminal 
kinase domain, a central CC region followed by a cysteine-rich 
(C1) motif, and a C-terminal Citron-Nik1 homology (CNH) 
domain (Fig. 3 A). All the fragments containing the CC region 
accumulated at the CF, whereas the kinase domain and the 
C1-CNH region showed diffuse cytoplasmic localization 
and causes excessive accumulation of phosphorylated MRLC at 
the cleavage site in late cytokinesis. Our findings indicate that 
Sti maintains correct RhoA localization at the cleavage site, 
which is in turn important for proper CR organization at the end 
of cytokinesis.
Results and discussion
CR constriction completes successfully in 
sti mutant neuroblasts
Time-lapse analyses indicated that CF ingression was unaffected 
in Drosophila S2 cells after sti RNAi (D’Avino et al., 2004; 
Echard et al., 2004). However, in both Sti-depleted S2 cells and 
sti mutant tissues, CR components accumulated abnormally at 
the cleavage site in late cytokinesis (D’Avino et al., 2004; Naim 
et al., 2004). These results suggest that Sti is not required for 
CR constriction but for proper CR organization in late cytokine-
sis. To further address this, we visualized CR dynamics in sti 
larval neuroblasts expressing the MRLC encoded by the spa-
ghetti squash (sqh) gene tagged with GFP (Royou et al., 2004). 
We found that CR ingression kinetics in sti mutant neuroblasts 
was similar to controls, albeit less uniform (Fig. 1 and Videos 1 
and 2), indicating that the defects in CR organization observed 
in the absence of Sti occurred after and not during CF ingression.
Sti localization to the CF requires Rho1 
and CR assembly
Previous studies indicated that Sti/CIT-K localization to the CF 
requires Pebble in flies and RhoA activity in human cells (Eda 
et al., 2001; Shandala et al., 2004). We confirmed that in Dro-
sophila S2 cells, RNAi depletion of Rho1, the single Drosoph-
ila RhoA homologue, prevented accumulation of Sti at the CF 
(Figs. 2 A and S1 A). The majority (61.5%, n = 104) of Rho1 
Figure 1. CR dynamics in sti mutant neuro­
blasts. (A and B) Kymographs of time-lapse 
imaging of sqh-GFP in a control stiGS9053/+ 
heterozygous (A) or stiGS9053/Df(3L)iro2 hemi-
zygous mutant (B) dividing larval brain neuro-
blast showing the progression of cytokinesis 
every 30 s. Bar, 1 µm. (C and D) Equatorial 
cell diameter during cytokinesis measured 
during live imaging of control stiGS9053/+ 
(C; n = 15) or stiGS9053/Df(3L)iro2 mutant 
(D; n = 14) neuroblast divisions. Time is 
indicated in seconds after Sqh-GFP concen-
tration at the cell equator. All cells imaged 
completed contraction within 5 min, with sti 
mutants showing both faster and slower con-
tractions than the more uniform controls.
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cell lines with a transgene expressing Sqh tagged with the Myc 
epitope and affinity purified PtA-tagged proteins and associated 
complexes. PtA::CC2a was able to pull down both actin and 
Myc::Sqh but not Rho1 (Fig. 3 C). Inhibition of actin polymer-
ization did not affect the ability of CC2a to pull down actin and 
Sqh (Fig. 3 D), suggesting that intact actomyosin is dispensable 
for this association. Consistent with these results, Sti colocalizes 
with F-actin (D’Avino et al., 2004) and Sqh at the CF (Fig. S2 B). 
Collectively, these findings indicate that Sti localizes to the CF 
via association of its CC2a region with actin and myosin.
Sti is necessary for proper Rho1 
localization in late cytokinesis
Because physical interaction with Rho1 was not required for 
Sti localization to the CF, we asked whether Rho1 localization 
could instead depend on Sti. To address this question, we 
visualized Rho1 localization during cytokinesis in sti RNAi 
cells by immunofluorescence. In the vast majority of control 
cells (93.7%, n = 205), Rho1 accumulated at the CF in early 
telophase cells and formed a compact ring around the spindle 
midzone in mid- and late telophase (Fig. 4 A). After Sti 
depletion, Rho1 localized normally at the CF at furrowing onset 
but was found diffuse and did not form a compact ring in 50.3% 
(n = 151) of mid- and late telophase cells (Fig. 4 A), a pheno-
type very rarely observed in control cells (2.4%, n = 205). 
Thus, Sti is necessary for proper Rho1 localization at the cleavage 
site in late telophase.
Shandala et al. (2004) reported that the C-terminal–most 
416 amino acids of Sti, which contain the CNH domain, was the 
(Fig. 3, A and B; and not depicted). To further narrow down 
the region responsible for Sti localization, we initially divided 
CC into two fragments, CC1 and CC2, on the basis of the Sti 
CC profile (Fig. S1 C). CC2 localized to the CF (Fig. 3 B), 
whereas CC1 accumulated at centrosomes in metaphase, weakly 
localized to central spindle microtubules in anaphase, and then 
accumulated strongly at the spindle midzone in telophase, 
where it remained until abscission (Figs. 3 B and S1 D). These 
results suggest that CC2 is sufficient to direct localization 
to the CF, whereas CC1 probably interacts with one or more 
microtubule-associated proteins. The distribution pattern of 
CC1 could also explain the vicinity of Sti to microtubules 
observed after depletion of Rho1 and Zipper (Fig. 2, A and B). 
However, because CC1 is not essential for CF localization, 
its function remains to be investigated.
Alignment of the CIT-K RhoA-binding domain (Madaule 
et al., 1995) with Sti identified a highly conserved region within 
CC2-spanning residues 1,235–1,263 that we named Rho-binding 
homology (RBH; Figs. 3 A and S2 A). A fragment containing 
RBH, CC2b, showed cytoplasmic localization (Fig. 3 B), whereas 
the region upstream of RBH, CC2a, showed a distribution 
identical to full-length Sti even after depletion of the endogenous 
protein (Fig. 3 B). These results indicate that RBH is not necessary 
for Sti localization and that CC2a has an independent ability to 
localize to the CF. To investigate whether CC2a could associate 
with Rho1 and/or CR components in vivo, we generated cell 
lines stably expressing either CC2a tagged with two copies of 
the IgG-binding domain of protein A (PtA) or PtA alone. Because 
no Sqh antibodies are available, we transiently transfected these 
Figure 2. Sti localization to the CF depends on RhoA and CR assembly. (A) Drosophila S2 cells were treated with dsRNAs directed against the bacterial 
kanamycin resistance gene (absent in Drosophila and used as a control) or Rho1 for 72 h and then fixed and stained to detect Sti, tubulin, and DNA. 
(B) S2 cells were treated with dsRNAs directed against kanamycin (control) or zipper for 84 h and then fixed and stained to detect Sti, tubulin, and DNA. 
Percentages on the left indicate localization of Sti. (C) S2 cells were treated with dsRNAs directed against kanamycin (control) or zipper for 84 h and then 
fixed and stained to detect Rho1, Sti, tubulin, and DNA (not depicted in the merged images). (D) Drosophila S2 cells were treated with latrunculin A (Lat-A) 
or its solvent DMSO for 1 h and then fixed and stained to detect Rho1, Sti, tubulin, and DNA (not depicted in the merged images). Bars, 10 µm.
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Figure 3. Sti localizes to the CF via interaction of its CC region with actin and myosin. (A) Schematic representation illustrating Sti protein domains and the 
localization of different Sti fragments tagged with GFP. (B) Drosophila S2 cells stably expressing various GFP-tagged Sti fragments (indicated at the top) 
were fixed and stained to detect GFP, tubulin, and DNA (blue). The arrow in the StiFL image marks a midbody remnant. In the CC1 image, the arrowhead 
marks the spindle midzone, whereas the arrow indicates CC1 localization to centrosome and astral microtubules. GFP::CC2a localization is shown in 
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early and late telophase and after treatment for 72 h with a dsRNA directed against the CNH region (sti RNAi). Bars, 10 µm. (C) S2 cells stably express-
ing either the Sti CC2a fragment tagged with PtA or PtA alone were transfected with a Myc::Sqh construct for 48 h, and then protein extracts were used 
in a PtA pull-down assay. The extracts and pull-downs were analyzed by Western blotting to detect Myc::Sqh, actin, Rho1, and PtA. (D) S2 cells stably 
expressing PtA::StiCC2a were transfected with a Myc::Sqh construct for 48 h and, 5 h before collection, treated either with Cytochalasin D (Cyto D) or its 
solvent DMSO. Protein extracts were then subject to PtA pull-down assay, and extracts and pull-downs were analyzed by Western blotting to detect Myc::
Sqh, actin, Rho1, and PtA. Numbers on the left indicate the sizes in kilodaltons of the molecular mass markers.
 
only region able to interact with a constitutively active variant 
of Rho1 in a yeast two-hybrid assay. To confirm and expand 
these findings, we tested whether two in vitro translated and 
radiolabeled polypeptides encompassing the CNH (Sti1,437–1,854) 
or RBH (Sti1,150–1,331; Fig. S2 A) domain could interact with re-
combinant wild-type (WT), constitutively active (G14V), and 
dominant-negative (T19N) variants of Rho1 expressed in bac-
teria. The Rho-binding domain (RBD) of Rhotekin, a known 
RhoA effector (Reid et al., 1996), was used as a control. In our 
conditions, Sti1,437–1,854 (containing CNH), but not Sti1,150–1,331 
(containing RBH), was pulled down by all three Rho1 variants 
with similar efficiency (Fig. 4 B). As expected, Rhotekin RBD 
interacted only with RhoWT and RhoG14V (Fig. 4 B). Our 
findings support the results of Shandala et al. (2004) that Sti 
interacts directly with Rho1 through its CNH domain. Because 
CNH is not required for CF localization (Fig. 3 B), these results 
further indicate that interaction with Rho1 is not necessary for 
Sti localization. Finally, the observation that the Sti CNH domain 
was able to interact with all three Rho1 variants, including 
dominant-negative RhoT19N (Fig. 4 B), indicates that Sti can-
not be considered a canonical RhoA effector.
To investigate whether proper Rho1 localization required 
Sti kinase activity or interaction with CNH, we tested whether 
StiCNH or a kinase-dead version of Sti (StiKD, containing two 
lysine to alanine substitutions in the predicted ATP-binding 
pocket; see Materials and methods) could rescue the cytokinesis 
defects and aberrant Rho1 localization caused by Sti deple-
tion. We specifically depleted the endogenous Sti protein in 
cell lines stably expressing one of the following Myc-tagged 
transgenes: Sti full length (StiFL), StiCNH, StiKD, or Myc 
alone. All these transgenes were expressed and localized properly 
in Drosophila cells (Fig. S3, A and B). A double-stranded RNA 
(dsRNA) directed against the sti 3 untranslated region (UTR), 
which is absent in all Myc-tagged transgenes, was used to de-
plete the endogenous Sti. This treatment caused a significant 
reduction of Sti expression, albeit at lower levels than another 
dsRNA directed against the Sti CNH region (Fig. S3 C), and 
this less effective knockdown was mirrored by a less penetrant 
cytokinesis defect (Fig. S3 D). StiFL fully rescued the cyto-
kinesis failure caused by RNAi of endogenous sti (98.0% rescue; 
Fig. 4 C), whereas StiKD showed only a partial rescue (47.2%) 
and StiCNH a more significant, although not complete, rescue 
(79.2%). Moreover, StiFL and StiCNH, but not StiKD, were 
able to rescue Rho1 localization after depletion of endogenous 
Sti (Fig. 4, D and E). Collectively, these findings indicate that 
proper Rho1 localization requires Sti kinase activity and not 
interaction of Rho1 with the CNH domain. However, the CNH 
domain is necessary for at least some Sti functions because 
StiCNH could not fully rescue the cytokinesis defects caused 
by sti 3UTR RNAi (Fig. 4 C).
Sti depletion causes excessive 
accumulation of mono- and 
diphosphorylated MRLC at the  
cleavage site
The Rho1 antibody used in our experiment (Fig. 4 A) was not 
specific for active Rho1, and thus, our results did not reveal 
whether Rho activation was also affected after sti RNAi. To try 
to address this issue, we generated stable cell lines express-
ing two RhoA activity sensors composed of the RBD of either 
Rhotekin or the formin Diaphanous tagged with GFP. Unfortu-
nately, neither sensor protein localized to the CF in Drosoph-
ila cells (unpublished data), and thus, we could not determine 
whether Sti knockdown affected Rho1 activity at the CF. To 
overcome this problem, we decided to analyze the level of 
MRLC phosphorylation as an indirect readout of Rho1 activ-
ity. We first determined whether Sti depletion had any effect 
on the accumulation of Sqh::GFP during cytokinesis. No sig-
nificant difference in the levels of Sqh::GFP at the CF was 
observed between control and sti RNAi cells in both early and 
late telophase (Fig. 5 A). However, Sqh::GFP failed to form a 
compact ring structure in late telophase sti RNAi cells (Fig. 5 A). 
This phenotype resembled that observed for other CR compo-
nents, such as F-Actin and Anillin (D’Avino et al., 2004), and 
confirmed that Sti is necessary to maintain a compact CR or-
ganization in late telophase. We then investigated whether Sti 
depletion could affect the levels of Sqh phosphorylation at the 
CF using two phosphospecific antibodies that recognize either 
the monophosphorylated (Sqh1P, phosphorylated at Ser21 in 
Drosophila and equivalent to Ser19 in human MRLC) or the 
diphosphorylated (Sqh2P, phosphorylated at Ser21 and Thr20) 
form of Sqh (Zhang and Ward, 2011). Sqh1P showed a distribu-
tion pattern identical to Sqh::GFP in control cells, whereas sti 
RNAi cells showed a twofold increase of Sqh1P at the CF in 
late, but not early, telophase cells (Fig. 5 B). As a control, we 
also monitored Sqh1P levels after depletion of ROK because it 
is well established that this kinase phosphorylates Sqh and is 
required for its recruitment to the CF (Winter et al., 2001; Dean 
et al., 2005). In agreement with these studies, we found that 
ROK depletion severely reduced Sqh1P accumulation at the CF 
(Fig. 5 B). No significant difference in Sqh2P levels at the 
CF was observed between control and sti RNAi cells in early 
telophase (Fig. 5 C). However, in late telophase, Sqh2P was 
detected only in very few control cells (9.0%, n = 199), whereas 
the majority of sti RNAi cells (67.1%, n = 183) showed a clear 
Sqh2P signal at the cleavage site in late cytokinesis (Fig. 5 C). 
Moreover, in these late telophase sti RNAi cells, Sqh2P often 
appeared to accumulate at one side of the cleavage site, distant 
from the spindle midzone (Fig. 5 C). These results indicate that 
Sti depletion causes an increase of mono- and diphosphorylated 
MRLC at the end of cytokinesis.
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Figure 4. Sti is required for proper localization of Rho1 at the CF. (A) Drosophila S2 cells were treated with dsRNAs directed against kanamycin (control) 
or sti for 72 h and then fixed and stained to detect Rho1, tubulin, and DNA (blue). (B) GST::Rho1 variants were preincubated with GTP and then mixed with 
Sti1,150–1,331, Sti1,437–1,854, or Rhotekin RBD, translated, and radiolabeled in vitro. The mixtures were then pulled down using glutathione beads, separated on 
SDS-PAGE gels, transferred onto nitrocellulose membrane, and exposed to x-ray films. The Ponceau S staining of protein loading is shown at the bottom. 
The numbers on the left indicate the sizes in kilodaltons of the molecular mass marker. (C) S2 cells stably expressing Myc alone or Myc-tagged Sti full length 
(StiFL), StiCNH, or a kinase-dead version of Sti (StiKD) were treated with dsRNAs directed against either kanamycin (kana) or the 3 UTR of sti for 72 h. 
The number of multinucleate cells was then counted and plotted. Only Myc-positive cells were counted, and >600 cells were counted in each experiment. 
(D) Quantification of the cells showing aberrant Rho1 localization from experiments performed as described in C. At least 120 cells were counted in each 
experiment. (E) Cells expressing the transgenes described in C and depleted of endogenous Sti were stained to detect Rho1, Myc, and tubulin. Bars, 10 µm. 
n = 4; *, P < 0.05 (Mann–Whitney U test). Error bars indicate standard deviations.
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Closing remarks
Current models propose that in human cells, RhoA recruits and 
then activates CIT-K, which in turn phosphorylates MRLC at 
the CF (Eda et al., 2001; Yamashiro et al., 2003). Results from 
our and another study (Dean and Spudich, 2006) indicate that, 
at least in Drosophila, this model is incorrect. Indeed, Sti re-
cruitment to the CF does not require interaction with RhoA, 
and instead, Sti appears necessary to maintain proper RhoA local-
ization at the CF specifically in late cytokinesis (Figs. 3 and 4). 
In addition, we found that Sti depletion caused an increase 
and not a decrease of mono- and diphosphorylated MRLC at 
the cleavage site in late cytokinesis (Fig. 5). Because MRLC 
phosphorylation is controlled by RhoA signaling (Dean and 
Spudich, 2006), we propose that aberrant RhoA localization 
after Sti depletion might cause an increase of phosphorylated 
MRLC at the CF. MRLC phosphorylation has been described 
to control actin dynamics (Murthy and Wadsworth, 2005), and 
thus, this model could well explain the CR disorganization 
Figure 5. Sti depletion causes an increase 
of phosphorylated Sqh at the CF in late cyto­
kinesis. (A) Drosophila S2 cells stably ex-
pressing Sqh::GFP were treated with dsRNAs 
directed against kanamycin (control) or sti 
for 72 h and then fixed and stained to de-
tect Sqh::GFP, tubulin, and DNA (blue). The 
box plots showing the quantification of Sqh::
GFP fluorescence levels at the CF in early 
and late cytokinesis are shown at the bottom. 
The intensity of Sqh::GFP fluorescence at the 
CF was calculated using the formula shown, 
in which ICF is the fluorescence intensity at 
the CF, and IC represents the background 
intensity measured within an identical area 
inside the cytoplasm. At least 30 cells from 
two separate experiments were analyzed. 
AU, arbitrary unit. (B) S2 cells were treated 
with dsRNAs directed against the kanamycin 
gene (control), sti, or rok for 72 h and then 
fixed and stained to detect Sqh1P, tubulin, 
and DNA (blue). Quantification of Sqh1P 
levels was performed as described in A. Note 
that the Sqh1P staining on centrosomes is not 
specific because it was not affected by ROK 
depletion, and Sqh::GFP never localized to 
centrosomes (Fig. S2 B). **, P < 0.01 (Stu-
dent’s t test). (C) S2 cells were treated with 
dsRNAs directed against kanamycin (con-
trol), sti, or rok for 72 h and then fixed and 
stained to detect Sqh2P, tubulin, and DNA 
(blue). In each box plot, the box contains 
the values comprised between the 25th and 
75th percentile, and the horizontal line inside 
the box marks the median. The ends of the 
whiskers indicate the minimum and maximum 
values. Bars, 10 µm.
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observed after Sti knockdown. Why does Sti depletion cause 
an increase of MRLC phosphorylation? The simplest hypotheses 
are that Sti kinase activity could, directly or indirectly, promote 
the activity of an MRLC phosphatase or inhibit RhoA and/or an 
MRLC kinase. Identification of Sti targets will be necessary to 
fully comprehend how this kinase controls RhoA localization 
during cytokinesis and to distinguish between the aforemen-
tioned hypotheses.
Materials and methods
Fly stocks and time­lapse analysis of larval neuroblasts
Flies were raised on a standard cornmeal medium at 25°C. The deficiency 
Df(3L)iro2 uncovers the sti genomic region (69B–69D6), and the stiGS9053 
allele is a P{GSv6} insertion in the 5UTR of sti as previously described 
(Shandala et al., 2004). The sqh::GFP stock contains a C-terminal fusion 
of MRLC with GFP (Royou et al., 2004). The His2Av::GFP stock contains a 
C-terminal fusion of His2Av with GFP as previously described in Clarkson 
and Saint (1999). For time-lapse analyses, brains were dissected from sti 
heterozygous (stiGS9053/+) or sti hemizygous (stiGS9053/Df(3L)iro2) third instar 
larvae, and neuroblasts were filmed by collecting images every 30 s as 
previously described (Savoian and Rieder, 2002). In brief, live brains were 
spread to a monolayer on a coverslip under halocarbon oil (Sigma-Aldrich) 
using scalpel blades and then mounted using Vaseline as a well. Live imag-
ing was performed at room temperature on a microscope (AX70; Olympus) 
using a 100× Plan Apochromat objective, NA 1.35. Images were acquired 
using a camera (CoolSNAP fx; Photometrics) with V++ software (Digital 
Optics), and kymographs were assembled in Photoshop (Adobe).
Molecular biology, cell culture, DNA, and dsRNA transfections
Gateway technology (Invitrogen) was used in all cloning procedures as 
previously described (D’Avino et al., 2006). Proteins tagged at the N or C 
terminus with GFP, Myc, or PtA were expressed in Drosophila cells under 
the control of either a constitutive Actin5C promoter or an inducible 
metallothionein promoter using the destination vectors described previ-
ously (D’Avino et al., 2006, 2008, 2009). The pDEST15 vector (Invitro-
gen) was used for bacterial expression of GST-tagged proteins. To generate 
the Sti kinase-dead mutant, two adjacent lysines (K) located in the 
predicted ATP-binding pocket of the kinase domain, K142 and K143, 
were mutated to alanine using a site-directed mutagenesis kit (QuikChange 
Lightning; Agilent Technologies) following the manufacturer’s instructions. 
K142 corresponds to K126 in CIT-K, which was shown to be essential for 
kinase activity (Di Cunto et al., 1998).
The Dmel strain of S2 cells (Invitrogen) was grown in serum-free 
medium (Express Five; Invitrogen) supplemented with antibiotics. To gener-
ate stable cell lines, three million cells were transfected with 3 µg of the 
appropriate vector along with 0.3 µg pCoBlast plasmid (Invitrogen) carry-
ing a resistance to the antibiotic blasticidin and 15 µl transfection reagent 
(FuGENE HD; Roche) following the manufacturer’s instructions. Resistant 
cells were selected by adding 20 µg/ml blasticidin to the media 48 h after 
transfection. For expression of metallothionein-regulated constructs, cells 
were incubated in complete medium containing 1 mM CuSO4 for 5–7 h.
dsRNA production and RNAi treatments were performed essentially 
as described previously (D’Avino et al., 2004). Typically, 1.5 million cells 
were transfected with 20 µg dsRNA and 20 µl transfection reagent (Trans-
Fast; Promega) following the manufacturer’s instructions and incubated for 
72 h unless otherwise indicated. The primers used to generate dsRNAs 
are listed in Table S1. The sti CNH dsRNA was used in all Sti knockdowns 
with the only exception of the rescue experiments shown in Fig. 3 B. For 
latrunculin A treatment, cells were plated on coverslips for 2 h and then 
treated for 1 h with either latrunculin A (Sigma-Aldrich) at a final concen-
tration of 20 µM or an equal volume of its solvent DMSO (Sigma-Aldrich) 
as a control.
Antibodies and microscopy
The following antibodies were used in this study: mouse monoclonal anti–
-tubulin (clone DM1A; Sigma-Aldrich), chicken polyclonal anti–-tubulin 
(ab89984; Abcam), mouse monoclonal antiactin (clone AC-40; Sigma-
Aldrich), mouse monoclonal anti-Myc (clone 9E10; Santa Cruz Biotechnol-
ogy, Inc.), rabbit polyclonal anti-Myc (ab9106; Abcam), rabbit polyclonal 
anti-Sti (D’Avino et al., 2004), mouse monoclonal anti-Rho1 (clone p1D9; 
Developmental Studies Hybridoma Bank), rat anti-Sqh2P and guinea pig 
anti-Sqh1P (provided by R. Ward, University of Kansas, Lawrence, KS; 
Zhang and Ward, 2011), rabbit polyclonal anti-MRLC S19 (Cell Signal-
ing Technology), peroxidase-ChromPure anti–rabbit IgG (Jackson Immuno-
Research Laboratories, Inc.), and Alexa Fluor 594 phalloidin (Invitrogen). 
Peroxidase- and Alexa Fluor–conjugated secondary antibodies were 
purchased from Jackson ImmunoResearch Laboratories, Inc. and Invitrogen.
Dmel cells were grown on 22 × 22–mm coverslips (Menzel-Gläser) 
and fixed in PHEM buffer (60 mM Pipes, 25 mM Hepes, pH 7, 10 mM 
EGTA, 4 mM MgCl2, and 3.7% formaldehyde) for 12 min. They were then 
washed three times for 10 min with PBS and incubated in blocking buffer 
(PBS, 0.5% Triton X-100, and 3–5% BSA) for 1 h at room temperature. 
Incubation with primary antibodies was performed overnight at 4°C in 
PBT (PBS, 0.1% Triton X-100, and 1% BSA). After two washes in PBT, 
coverslips were incubated with Alexa Fluor–conjugated secondary anti-
bodies (Invitrogen) diluted in PBT for 2 h at room temperature and then 
washed two times with PBT and once with PBS. Coverslips were finally 
mounted using mounting medium with DAPI (Vectashield; Vector Labora-
tories) and visualized on a fluorescence microscope (Axiovert 200; Carl 
Zeiss) equipped with a 100× objective, NA 1.4. Images were acquired 
using a camera (CoolSNAP HQ2; Photometrics) with MetaMorph software 
(Molecular Devices) and assembled and adjusted for contrast using Photo-
shop CS3. Quantification of Sqh fluorescence was performed using ImageJ 
software (National Institutes of Health), and fluorescence intensity values 
were plotted using Excel software (Microsoft).
In vivo pull­down assays
Cells stably expressing either PtA::CC2a or PtA alone were transfected 
with a plasmid encoding a Myc-tagged Sqh transgene and incubated 
at 25°C for 42 h, and then the proteasome inhibitor MG132 (Sigma-
Aldrich) was added to the medium at a concentration of 25 µM, 5–6 h 
before harvesting the cells. Cytochalasin D was added 5 h before col-
lection at a final concentration of 10 µM. Cells were then collected and 
stored at 80°C. The cell pellet was resuspended in 0.5 ml extrac-
tion buffer (50 mM Hepes, pH 7.5, 100 mM KAc, 50 mM KCl, 2 mM 
MgCl2, 2 mM EGTA, 0.1% NP-40, 5 mM DTT, 5% glycerol and protease 
inhibitors [Complete; Roche]) and homogenized using a high-performance 
disperser (Thermo Fisher Scientific). Homogenates were centrifuged at 
8,000 rpm at 4°C in a centrifuge (5417R; Eppendorf) for 20 min, and 
supernatants were transferred into new tubes. 50 µl Dynabeads (Invitro-
gen) conjugated to rabbit IgG (MP Biochemicals) was added to the super-
natants and incubated for 2 h on a rotating wheel at 4°C. Beads were 
then washed five times for 5 min in 1 ml extraction buffer. Proteins were 
eluted from beads with 0.5 ml elution buffer (0.5 M NH4OH and 0.5 mM 
EDTA, pH 8.0), lyophilized, and resuspended in Laemmli SDS-PAGE 
sample buffer (Sigma-Aldrich). Proteins were separated on a SDS-PAGE 
gel, transferred onto a polyvinylidene fluoride membrane, and probed to 
detect the antigens shown in Fig. 3 (C and D).
In vitro binding assay
DNA fragments coding for RhoWT, RhoG14V, and RhoT19N were gener-
ated by PCR and cloned into pDEST15 (Invitrogen) to express N-terminal 
GST-tagged polypeptides in Escherichia coli. The GST-tagged products 
were then purified using glutathione–Sepharose 4B according to 
manufacturer’s instruction (GE Healthcare). [35S]Methionine-labeled RBH, 
CNH, and Rhotekin RBD (provided by A. Miller and B. Bement, University 
of Wisconsin–Madison, Madison, WI) were prepared from corresponding 
PCR products amplified using primers harboring a T7 promoter and then 
transcribed and translated in vitro using a transcription/translation system 
(TnT T7 Quick Coupled; Promega) in the presence of [35S]methionine. 
Generally, 25 µl glutathione–Sepharose beads containing purified GST-Rho1 
proteins (WT, G14V, and T19N) was preincubated in 300 µl NET-N+ 
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% 
NP-40, and a cocktail of protease inhibitors [Complete]) containing 5 mM 
GTP (Sigma-Aldrich) at 4°C, and after 1 min, 17 mM MgCl2 was added, 
and the incubation continued for a further 29 min. Then, 10 µl [35S]methionine-
labeled polypeptides were added, and the mixture was incubated for 1 h 
at 4°C with periodic agitation. Samples were then washed five times with 
500 µl wash buffer (50 mM Tris-HCl, pH 7.4, 500 mM NaCl, 5 mM EDTA, 
5 mM GTP, 0.5% NP-40, and a cocktail of protease inhibitors [Complete]) 
followed by centrifugation at 500 g for 1 min. Beads were resuspended in 
25 µl Laemmli SDS-PAGE sample buffer, and typically 15 µl was loaded on 
a 4–20% Tris-glycine gel. Proteins were then transferred onto a nitrocellu-
lose membrane using a dry blotting system (iBlot; Invitrogen) and exposed 
to x-ray films at 80°C with intensifying screens (Sigma-Aldrich). The filters 
were then stained with Ponceau S to detect GST-tagged proteins.
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